39 results about "Asialoganglioside" patented technology

The invention relates to a medicinal preparation for promoting healing of body surface injury and a method for preparing the medicinal preparation. Silver sulfadiazine (a), pain killers (b), asiaticoside (c) and other pharmaceutically acceptable carriers (d) are compatible with one another according to suitable proportions to obtain the medicinal preparation. The medicinal preparation and the method have the advantages that the medicinal preparation has double synergistic antibacterial and pain alleviating functions, accordingly, healing of wound surfaces can be promoted, epidermis hyperpigmentation due to the silver sulfadiazine can be prevented, and scar can be reduced; the shortcomings of poor hydrophilicity after existing pain killers and existing silver sulfadiazine are directly compatible with one another and easiness in volatilizing moisture in wound surfaces can be overcome.

The invention discloses a skin care product for improving skin anti-sensitivity and repairing ability, which is made of the following raw materials: 30-90 parts of pachysan, 0.1-10 parts of glycerin, 0.1-5 parts of trimethylglycine, and 0.01 parts of baicalin -3 parts, glycyrrhizin 0.01-5 parts, asiaticoside 0.01-5 parts, deionized water 0-69.77 parts. The present invention selects amino acid moisturizer with natural structure and naturally sourced polysaccharide compound, which can not only rapidly improve the water retention capacity of the skin, firmly lock the water, stimulate cell vitality, but also improve the skin's response to baicalin and glycyrrhizin. , asiaticoside and other natural anti-inflammatory active ingredients, so as to play anti-inflammatory and anti-itching effects, improve skin anti-sensitivity and repair ability; the formula is simple, and the raw materials are almost all derived from plant ingredients, avoiding the stimulation of chemical synthetic ingredients , can effectively improve the redness, swelling, itching, peeling and other symptoms of sensitive skin, make the skin feel comfortable and safe and re-establish the skin barrier function; the preparation process is simple and the cost is low.

The invention relates to a plant active component composition with slow anti-allergic action. The plant active component composition is mainly prepared from natural plant active components: 0.1-5wt% of glycyrrhetinic acid, 0.05-1wt% of apigenin, 0.05-1% of table gallic catechin gallic acid ester, 0.1-3wt% of asiaticoside, 0.1-5wt% of baicalin and 0.1-10wt% of fucus serratus extract. The composition is used for preparing cosmetics or personal care products with a plurality of effects of resisting skin allergy, diminishing inflammation, relieving itching, resisting oxidation, moisturizing and the like. The composition is safe and free of toxic and side effects, and can be compounded with a plurality of components, sensitive skin and dry skin are effectively improved, and the barrier function of the skin is reinforced.

The invention belongs to the field of medical preparations, and in particular relates to a liquid wound dressing and a preparation method thereof. The liquid wound dressing of the present invention comprises the following components in mass percentage: 52.29% to 78% antibacterial liquid, 8.51% to 29.5% healing liquid and 10% % to 20% film-forming agent; based on the mass percentage of the liquid wound dressing, the healing liquid contains 0.01% to 0.5% hyaluronic acid and 0.5% to 3% asiaticoside; the antibacterial liquid contains 0.09% to 0.9% Antimicrobial peptides and 0.9% to 9% chitosan. The liquid wound dressing of the invention has good air permeability and water resistance, has a delicate smell, is easy to peel off after film formation, has short film formation time, and has excellent antibacterial and wound healing effects.

A kind of spinning, which is made by blending PLGA, PEO and asiaticoside through stable jet electrospinning technology, and has the same orientation. Wherein, the weight ratio of PLGA to PEO is 4:1, and the dosage of asiaticoside is 10wt% of PLGA. The spinning of the present invention has significantly improved hydrophilicity, has the effect of regulating macrophage phenotype transformation and anti-inflammation in vivo, and can be used to prepare medicines or medical devices for regulating macrophage phenotype transformation and anti-inflammation in vivo (such as: stand).

The invention discloses asiaticoside-chitosan-sodium alginate microspheres, a preparation method and application thereof, and belongs to the technical field of biomedical materials. The microspheres are prepared by an emulsification cross-linking method and finally obtained by freeze-drying. The preparation method comprises the following steps: 1) preparing sodium alginate solution and asiaticoside-chitosan acetic acid solution respectively; 2) slowly and uniformly adding sodium alginate solution to the oil phase, stirring at high speed to form colostrum; 3) ) Slowly and evenly add the asiaticoside-chitosan acetic acid solution to the colostrum, stir, and fully emulsify; 4) Slowly and evenly add the glyceraldehyde solution to cross-link and solidify, centrifuge, and the precipitate is washed with petroleum ether successively. washing, washing with absolute ethanol, and vacuum freeze-drying to obtain light yellow powder of asiaticoside-sodium alginate-chitosan microspheres.

The invention belongs to the technical field of make-ups, and particularly relates to an acne removing preparation. The acne removing preparation is prepared from the following components in parts byweight: 1-3 parts of plant oil control factor, 0.5-2 parts of carboxymethyl yeast beta-glucan, 3-10 parts of acne bane, 0.2-1 part of asiaticoside, 0.05-0.2 part of dipotassium glycyrrhizinate and 1-6parts of folium / caulis myrothamni flabellifoliae extract. The preparation has a fast significant acne removing effect, a scar removing effect, an effect of significantly removing active oxygen in neutrophil, a bacteriostasis effect, effects of enhancing cell activity and promoting TIMP-1 factor secretion, and more uncommonly, a very good effect of repairing scars left in a disease course within one year.

The invention discloses for the first time the application of asiaticoside in the preparation of medicaments for treating skin cancer. The results of the DMBA / TPA two-step chemically induced mouse skin cancer model show that the therapeutic effect of asiaticoside on skin cancer is significantly better than that of the drugs used to treat scars, other AMPK agonists, clinical drugs for other cancers, and similar structures. medicine. The present invention provides a new drug choice for clinical treatment of skin cancer.